Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362476670> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4362476670 abstract "<div>Abstract<p>Acquired resistance to selective estrogen receptor (ER) modulators (SERM) and downregulators (SERD) is a significant clinical problem in the treatment of estrogen (E2) receptor-positive (ER<sup>+</sup>) breast cancers. There are two ER subtypes, ERα and ERβ, which promote and inhibit breast cancer cell proliferation, respectively. Although ER<sup>+</sup> breast cancers typically express a high ratio of ERα to ERβ, the acquisition of SERM resistance <i>in vitro</i> and <i>in vivo</i> is associated with increased relative expression of the ERβ. On some gene enhancers, ERβ has been shown to function in opposition to the ERα in the presence of E2. Here, we demonstrate that two different ERβ agonists, WAY-20070 and a novel “A-CD” estrogen called L17, produce a marked reduction in G<sub>2</sub>–M phase correlated with effects on cyclin D1 and cyclin E expression in a SERM/SERD-resistant breast cancer cell line. ERβ agonists recruited both the ERα and ERβ to the <i>Bcl-2</i> E2-response element strongly reducing <i>Bcl-2</i> mRNA and protein in an ERβ-dependent manner. L17 recruited RIP140 to the <i>Bcl-2</i> promoter in cells overexpressing ERβ. Exposure to the ERβ ligands also resulted in increased processing of LC3-I to LC3-II, indicative of enhanced autophagic flux. The coaddition of ERβ agonist and the autophagy inhibitor chloroquine resulted in a significant accumulation of sub-G<sub>1</sub> DNA which was completely prevented by the addition of the caspase inhibitor Z-VAD-FMK. We propose that combined therapies with an ERβ agonist and an inhibitor of autophagy may provide the basis for a novel approach to the treatment of SERM/SERD-resistant breast cancers. <i>Mol Cancer Ther; 13(7); 1882–93. ©2014 AACR</i>.</p></div>" @default.
- W4362476670 created "2023-04-05" @default.
- W4362476670 creator A5030570722 @default.
- W4362476670 creator A5030941843 @default.
- W4362476670 creator A5034116486 @default.
- W4362476670 creator A5049615740 @default.
- W4362476670 creator A5051115945 @default.
- W4362476670 creator A5077629568 @default.
- W4362476670 creator A5084745359 @default.
- W4362476670 creator A5086664258 @default.
- W4362476670 creator A5091562143 @default.
- W4362476670 date "2023-04-03" @default.
- W4362476670 modified "2023-09-29" @default.
- W4362476670 title "Data from Preferential Estrogen Receptor β Ligands Reduce Bcl-2 Expression in Hormone-Resistant Breast Cancer Cells to Increase Autophagy" @default.
- W4362476670 doi "https://doi.org/10.1158/1535-7163.c.6536676.v1" @default.
- W4362476670 hasPublicationYear "2023" @default.
- W4362476670 type Work @default.
- W4362476670 citedByCount "0" @default.
- W4362476670 crossrefType "posted-content" @default.
- W4362476670 hasAuthorship W4362476670A5030570722 @default.
- W4362476670 hasAuthorship W4362476670A5030941843 @default.
- W4362476670 hasAuthorship W4362476670A5034116486 @default.
- W4362476670 hasAuthorship W4362476670A5049615740 @default.
- W4362476670 hasAuthorship W4362476670A5051115945 @default.
- W4362476670 hasAuthorship W4362476670A5077629568 @default.
- W4362476670 hasAuthorship W4362476670A5084745359 @default.
- W4362476670 hasAuthorship W4362476670A5086664258 @default.
- W4362476670 hasAuthorship W4362476670A5091562143 @default.
- W4362476670 hasBestOaLocation W43624766702 @default.
- W4362476670 hasConcept C121608353 @default.
- W4362476670 hasConcept C126322002 @default.
- W4362476670 hasConcept C134018914 @default.
- W4362476670 hasConcept C172313692 @default.
- W4362476670 hasConcept C185592680 @default.
- W4362476670 hasConcept C199835354 @default.
- W4362476670 hasConcept C2777164284 @default.
- W4362476670 hasConcept C2777944059 @default.
- W4362476670 hasConcept C29537977 @default.
- W4362476670 hasConcept C502942594 @default.
- W4362476670 hasConcept C530470458 @default.
- W4362476670 hasConcept C71924100 @default.
- W4362476670 hasConcept C84606932 @default.
- W4362476670 hasConcept C86803240 @default.
- W4362476670 hasConceptScore W4362476670C121608353 @default.
- W4362476670 hasConceptScore W4362476670C126322002 @default.
- W4362476670 hasConceptScore W4362476670C134018914 @default.
- W4362476670 hasConceptScore W4362476670C172313692 @default.
- W4362476670 hasConceptScore W4362476670C185592680 @default.
- W4362476670 hasConceptScore W4362476670C199835354 @default.
- W4362476670 hasConceptScore W4362476670C2777164284 @default.
- W4362476670 hasConceptScore W4362476670C2777944059 @default.
- W4362476670 hasConceptScore W4362476670C29537977 @default.
- W4362476670 hasConceptScore W4362476670C502942594 @default.
- W4362476670 hasConceptScore W4362476670C530470458 @default.
- W4362476670 hasConceptScore W4362476670C71924100 @default.
- W4362476670 hasConceptScore W4362476670C84606932 @default.
- W4362476670 hasConceptScore W4362476670C86803240 @default.
- W4362476670 hasLocation W43624766701 @default.
- W4362476670 hasLocation W43624766702 @default.
- W4362476670 hasOpenAccess W4362476670 @default.
- W4362476670 hasPrimaryLocation W43624766701 @default.
- W4362476670 hasRelatedWork W1561036669 @default.
- W4362476670 hasRelatedWork W1599272461 @default.
- W4362476670 hasRelatedWork W2038599327 @default.
- W4362476670 hasRelatedWork W2068408721 @default.
- W4362476670 hasRelatedWork W2093476509 @default.
- W4362476670 hasRelatedWork W2101821182 @default.
- W4362476670 hasRelatedWork W2113093700 @default.
- W4362476670 hasRelatedWork W2150216118 @default.
- W4362476670 hasRelatedWork W2151094400 @default.
- W4362476670 hasRelatedWork W2461592119 @default.
- W4362476670 isParatext "false" @default.
- W4362476670 isRetracted "false" @default.
- W4362476670 workType "article" @default.